Multimedia
Healthy Outcomes: Key factors and trends impacting M&A activity in the healthcare industry
May 03, 2022 · Authored by Mark J. Ross, Michael Demers
On this podcast episode of Healthy Outcomes, our host Mark Ross interviews Baker Tilly Capital managing director Michael Demers about merger and acquisition (M&A) trends within the healthcare industry throughout 2020 and 2021. In addition to giving context about how the coronavirus pandemic and other factors have caused changing fluctuations in transactions, Ross and Demers discuss their predictions of what M&A activity will look like in 2022 and beyond, as well as what buyers and sellers are looking for when looking to acquire or be acquired.
Topics of discussion include:
- Healthcare M&A transaction volume in 2020 and 2021
- The coronavirus’ impact on healthcare investment opportunities
- Trends and demographic changes that are influencing healthcare transactions
- Healthcare M&A multiples
- Expectations about healthcare M&A activity in 2022 and beyond
Connect with us to hear more about our healthcare team.
About our host and guest
Mark J. Ross
Mark Ross is a principal with Baker Tilly’s healthcare practice.
Michael Demers
Michael Demers is a managing director with Baker Tilly Capital, LLC, the private investment banking subsidiary of Baker Tilly.
Whitepaper
Healthcare M&A update: 2021 healthcare M&A on the rise
Get a better understanding of the current M&A landscape in the healthcare industry with our H2 2021 report.
Listen to this podcast now
Listen to more podcasts in this seriesListen or subscribe to Healthy Outcomes on your favorite platform.
